about
Stable isotope-resolved metabolomics and applications for drug developmentTargeting amino acid metabolism in cancer growth and anti-tumor immune responseDysregulated metabolism contributes to oncogenesisIs cancer a metabolic disease?Glutamine and cancer: cell biology, physiology, and clinical opportunitiesTargeting mitochondria metabolism for cancer therapyReexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effectSIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growthOxamate Improves Glycemic Control and Insulin Sensitivity via Inhibition of Tissue Lactate Production in db/db MiceWarburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxolOverexpression, purification, crystallization and structure determination of AspB, a putative aspartate aminotransferase from Mycobacterium tuberculosis.Identification of proteins differentially expressed in gastric cancer cells with high metastatic potential for invasion to lymph nodesMalate-aspartate shuttle mediates the intracellular ATP levels, antioxidation capacity and survival of differentiated PC12 cells.Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia.Glutamine addiction: a new therapeutic target in cancerNon-viral nanocarriers for siRNA delivery in breast cancer.Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesisSynergistic anti-cancer effect of phenformin and oxamate.Metabolic Consequences of LDHA inhibition by Epigallocatechin Gallate and Oxamate in MIA PaCa-2 Pancreatic Cancer Cells.Metabolic characterization of triple negative breast cancer.The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancerStable isotope resolved metabolomics of lung cancer in a SCID mouse modelPharmacometabolomics: implications for clinical pharmacology and systems pharmacology.Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancerDrugging the undruggable RAS: Mission possible?Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs.Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.Therapeutic targeting of cancer cell metabolism.Aralar plays a significant role in maintaining the survival and mitochondrial membrane potential of BV2 microglia.Frex and FrexH: Indicators of metabolic states in living cells.Mammary carcinogen-protein binding potentials: novel and biologically relevant structure-activity relationship model descriptorsEnzyme Tunnels and Gates As Relevant Targets in Drug Design.Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients.Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate.Anticancer agents that counteract tumor glycolysis.Lowered circulating aspartate is a metabolic feature of human breast cancerAltered energy metabolism in cancer: a unique opportunity for therapeutic intervention.Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway.A Proteomic Approach for the Identification of Up-Regulated Proteins Involved in the Metabolic Process of the Leiomyoma.
P2860
Q24629149-D683CE2D-BA31-4CFE-90B3-0A0E78B88CC1Q26775425-DA02BD6B-83A8-4A98-853E-3DE7A1EA720CQ26784630-77998310-4029-411E-8540-9B5712BAACDFQ26852241-5CAB5DCB-B8CB-4B54-9510-715209806D70Q27011818-73D65501-45C4-46F4-9CA0-F751887B2B1FQ27027219-3DCC4BA6-D61D-4C6C-8E9D-B6653A60EBADQ28077883-43F2C3E6-2F96-4DF5-ABB2-B0BE9E244C77Q28258574-052A8604-0843-4690-AD5A-39DE1C39E101Q28550524-A10FFD91-690E-4FD9-B6EA-CD6E58CD63C9Q33691999-0A0D4892-FE7E-4733-BA69-B8EFDB759428Q33872845-EA48CD96-766F-4262-82FB-FE02C21E9792Q33886949-AF5D7C66-01B1-4539-A1CD-E1C0036CF8F6Q33932637-AEB58DCC-7069-46C6-8E81-F55D5580CD0DQ33996661-5C3E317A-763F-4740-8806-B7453E9115C4Q34050094-1CAD14C5-E4BF-4D5B-A27B-0E6F8AFBC662Q34079608-E8DABE24-A6CF-479E-A270-5B41F354BA3BQ34205937-1536AF3C-FAA1-4E32-873D-EEEC78870E76Q34400208-2CF79DC4-7F95-4D24-ACAD-CA236D95878CQ34488481-FA1F51AF-B6FC-4B37-B06C-376938E58221Q34967995-742E501E-FB56-4B22-8BBC-19DDC3EC5989Q35016080-DBB40591-BC71-486C-904A-A736297FEC27Q35030808-0929AB60-5864-4246-9D2A-E38515F77BE5Q35032056-6A89D220-3BAF-4935-A37D-F880DAD152BBQ35057121-1425C371-FE33-4791-85E0-8D55005D3965Q35075007-9A2F363A-E0D4-4F87-A7DF-AB0CA7453259Q35163434-E52EE924-4764-4AA0-A53B-0870B8706209Q35567256-5EF8E9FC-0637-46D7-89FF-25FBCFCBA2F9Q35836097-9A4D498E-36E2-41DF-9D64-B60EE92C2CDFQ35936525-D998534F-8D96-4F11-B6DF-E4273F0952ABQ35997660-7012DC47-A111-4A9F-A8FC-B6D0AABE0436Q36019316-3D88F6D3-E17A-41A9-9756-391B92FFFE25Q36057925-1F309BBE-FEED-402B-B0DD-68AD39DE6198Q36221405-B3058558-F0ED-40BB-BF7E-D5C80E002C9AQ36309665-DD6C404E-7571-48D5-A422-63293E56E04FQ36416507-84A96B55-9EB5-49C9-A9CC-B95785863636Q36452381-0B8F43B8-FB07-46A8-90A7-6971D5345926Q36545166-D6FEAB72-820E-43D8-8468-E3578C6E557FQ36608747-E235385F-CE99-4E2A-B2F1-1FD2E8C9ECCFQ36819538-4379DA7F-8C76-4976-98AE-B9CF8C84CCCEQ36847152-91257B20-16F9-4C4B-AD19-6E95ECE1186C
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Targeting aspartate aminotransferase in breast cancer
@ast
Targeting aspartate aminotransferase in breast cancer
@en
Targeting aspartate aminotransferase in breast cancer
@en-gb
Targeting aspartate aminotransferase in breast cancer
@nl
type
label
Targeting aspartate aminotransferase in breast cancer
@ast
Targeting aspartate aminotransferase in breast cancer
@en
Targeting aspartate aminotransferase in breast cancer
@en-gb
Targeting aspartate aminotransferase in breast cancer
@nl
prefLabel
Targeting aspartate aminotransferase in breast cancer
@ast
Targeting aspartate aminotransferase in breast cancer
@en
Targeting aspartate aminotransferase in breast cancer
@en-gb
Targeting aspartate aminotransferase in breast cancer
@nl
P2093
P2860
P3181
P356
P1476
Targeting aspartate aminotransferase in breast cancer
@en
P2093
Allan Simmons
Andrew N Lane
Brian F Clem
Jason Chesney
John W Eaton
Joshua Marshall Thornburg
Kristin K Nelson
Sengodagounder Arumugam
Sucheta Telang
P2860
P2888
P3181
P356
10.1186/BCR2154
P407
P577
2008-01-01T00:00:00Z
P5875
P6179
1005518856